Patents by Inventor Jobst Krauskopf

Jobst Krauskopf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fractions of whey permeate and use thereof for the prevention and therapy of type 2 diabetes and the metabolic syndrome
    Patent number: 9877995
    Abstract: Fractions of whey permeate, preferably made of sweet whey permeate and more preferably of hydrolyzed or partially hydrolyzed sweet whey permeate are provided, particularly for use in the production of pharmaceutical compositions, or of food, for the treatment, prophylaxis, or alleviation of glucose intolerance and insulin resistance, and thus of symptoms of the metabolic syndrome, type 2 diabetes, and complications in humans.
    Type: Grant
    Filed: August 3, 2007
    Date of Patent: January 30, 2018
    Assignee: S.U.K. BETEILIGUNGS GMBH
    Inventor: Jobst Krauskopf
  • Use of whey permeate for the treatment of metabolic syndrome
    Patent number: 9770468
    Abstract: The invention relates to the use of whey permeate, preferably sweet whey permeate and more preferably hydrolysed or partially-hydrolysed sweet whey permeate for the production of a pharmaceutical composition for prophylaxis or treatment of symptoms of metabolic syndrome, type-2 diabetes and secondary diseases, said composition being provided for a mammal.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: September 26, 2017
    Inventors: Jobst Krauskopf, Christian Sowada
  • USE OF WHEY PERMEATE FOR THE TREATMENT OF METABOLIC SYNDROME
    Publication number: 20140017282
    Abstract: The invention relates to the use of whey permeate, preferably sweet whey permeate and more preferably hydrolysed or partially-hydrolysed sweet whey permeate for the production of a pharmaceutical composition for prophylaxis or treatment of symptoms of metabolic syndrome, type-2 diabetes and secondary diseases, said composition being provided for a mammal.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 16, 2014
    Applicant: "S.U.K." BETEILIGUNGS GMBH
    Inventors: Jobst Krauskopf, Christian Sowada
  • FRAKTIONEN AUS MOLKEPERMEAT UND DEREN VERWENDUNG ZUR PRAVENTION UND THERAPIE DES TYP-2 DIABETES UND DES METABOLISCHEN SYNDROMS
    Publication number: 20090274768
    Abstract: Fractions of whey permeate, preferably made, of sweet whey permeate and more preferably of hydrolyzed or partially hydrolyze sweet whey permeate are provided, particularly for use in the production of pharmaceutical compositions, or of food, for the treatment, prophylaxis, or alleviation of glucose intolerance and insulin resistance, and thus of symptoms of the metabolic syndrome, type 2 diabetes, and complications in humans.
    Type: Application
    Filed: August 3, 2007
    Publication date: November 5, 2009
    Applicant: S.u.K. BETEILIGUNGS GMBH
    Inventor: Jobst Krauskopf
  • Use of a lactate salt for the treatment and prophylaxis of atherosclerosis
    Patent number: 7358277
    Abstract: The use of a lactate metal salt, in particular an L-lactate, for the treatment of atheroscloerosis and/or for the prophylaxis or treatment of diseases caused by atherosclerosis is disclosed.
    Type: Grant
    Filed: July 22, 2002
    Date of Patent: April 15, 2008
    Assignee: S.K. Enterprise GmbH
    Inventors: Jobst Krauskopf, Erich Eistner
  • Use of Whey Permeate for the Treatment of Metabolic Syndrome
    Publication number: 20070243231
    Abstract: The invention relates to the use of whey permeate, preferably sweet whey permeate and more preferably hydrolysed or partially-hydrolysed sweet whey permeate for the production of a pharmaceutical composition for prophylaxis or treatment of symptoms of metabolic syndrome, type-2 diabetes and secondary diseases, said composition being provided for a mammal.
    Type: Application
    Filed: July 12, 2004
    Publication date: October 18, 2007
    Inventors: Jobst Krauskopf, Christian Sowada
  • Calcium lactate and whey permeate for lowering the triglyceride level
    Publication number: 20060115538
    Abstract: Disclosed is the combined use of calcium lactate and whey permeate for the prophylaxis or treatment of hypertriglyceridemia and/or symptoms thereof.
    Type: Application
    Filed: July 22, 2003
    Publication date: June 1, 2006
    Inventors: Jobst Krauskopf, Christian Sowada
  • Use of a lactate salt for the treatment and prophylaxis of atherosclerosis
    Publication number: 20040214892
    Abstract: The use of a lactate metal salt, in particular an L-lactate, for the treatment of atheroscloerosis and/or for the prophylaxis or treatment of diseases caused by atherosclerosis is disclosed.
    Type: Application
    Filed: June 29, 2004
    Publication date: October 28, 2004
    Inventors: Jobst Krauskopf, Erich Elstner